We are live on ! Find out more
AUGX

Augmedix, Inc. Common Stock
AUGX

Delisted

AUGX was delisted on the 1st of October, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Augmedix, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 45 → 0 (-45)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $84.4M → $0 (-$84.4M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 44

Holders
–
Holders Change
-45
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
44
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$38.5M
2
BCM
Beryl Capital Management
California
-$10.6M
3
OBAM
ODDO BHF Asset Management
France
-$5.7M
4
SM
Samjo Management
New York
-$4.23M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$3.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
RG
1
Redmile Group
California
– -$38.5M -16,380,327 Closed
BCM
2
Beryl Capital Management
California
– -$10.6M -4,492,772 Closed
OBAM
3
ODDO BHF Asset Management
France
– -$5.7M -2,425,000 Closed
SM
4
Samjo Management
New York
– -$4.23M -1,799,000 Closed
Vanguard Group
5
Vanguard Group
Pennsylvania
– -$3.73M -1,589,255 Closed
GF
6
Gabelli Funds
New York
– -$2.93M -1,247,622 Closed
TC
7
Trium Capital
United Kingdom
– -$2.78M -1,182,119 Closed
GCIA
8
Gabelli & Co Investment Advisers
New York
– -$2.38M -1,013,150 Closed
HIM
9
HGC Investment Management
Ontario, Canada
– -$1.94M -825,424 Closed
Russell Investments Group
10
Russell Investments Group
United Kingdom
– -$1.56M -664,306 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
– -$1.31M -556,611 Closed
AFG
12
American Financial Group
Ohio
– -$1.18M -500,000 Closed
Millennium Management
13
Millennium Management
New York
– -$1.05M -447,128 Closed
OAC
14
OMERS Administration Corp
Ontario, Canada
– -$861K -366,340 Closed
OAM
15
Oxford Asset Management
United Kingdom
– -$796K -338,716 Closed
Boston Partners
16
Boston Partners
Massachusetts
– -$738K -314,067 Closed
BlackRock
17
BlackRock
New York
– -$417K -177,372 Closed
PCM
18
PenderFund Capital Management
British Columbia, Canada
– -$513K -161,327 Closed
VAM
19
Vazirani Asset Management
New York
– -$355K -151,184 Closed
State Street
20
State Street
Massachusetts
– -$353K -150,413 Closed
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
– -$307K -130,434 Closed
Northern Trust
22
Northern Trust
Illinois
– -$268K -113,887 Closed
CL
23
CSS LLC
Illinois
– -$264K -112,427 Closed
Morgan Stanley
24
Morgan Stanley
New York
– -$248K -105,401 Closed
PCM
25
Prelude Capital Management
New York
– -$215K -91,439 Closed
1
2

AUGX Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q4 2024, worth a combined $0 — down 100% from $84.4M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of AUGX and 0 opened new positions — a net loss of 44 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Redmile Group, exiting entirely with an estimated $38.5M sold.

  • 0 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q4 2024, down from 45 in Q3 2024.
  • Funds reported $0 of Augmedix, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Augmedix, Inc. Common Stock positions in Q4 2024 and 44 closed out, a net change of -44 holders.
  • The largest Augmedix, Inc. Common Stock seller in Q4 2024 was Redmile Group, an estimated $38.5M sold.

Based on aggregated 13F filings for Q4 2024.